MARKET

LVCLF

LVCLF

Algorae Pharmaceuticals
OTCPK
0.0035
NaN%
Closed 09:30 11/19 EST
OPEN
--
PREV CLOSE
0.0035
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0035
52 WEEK LOW
0.0035
MARKET CAP
7.10M
P/E (TTM)
-3.5000
1D
5D
1M
3M
1Y
5Y
1D
Algorae Discloses Director’s Indirect Acquisition of Shares
TipRanks · 3d ago
Algorae Pharmaceuticals Reports Director Interest Change
TipRanks · 11/11 08:02
Algorae Pharmaceuticals Receives Strong AGM Shareholder Support
TipRanks · 11/05 03:07
Algorae Expands Pharmaceutical Portfolio and Validates AI Drug Discovery Platform
TipRanks · 11/04 23:07
Algorae Pharma Issues Non-Deal Investor Presentation with Comprehensive Disclaimers
TipRanks · 10/29 22:57
Algorae Pharmaceuticals secures NSW Health supply role and advances AI drug‑discovery platform
TipRanks · 10/29 22:56
Algorae Pharmaceuticals Tightens Governance With Updated Securities Trading Policy
TipRanks · 10/28 07:53
AlgoraeRx inks Umedica supply deals to deepen Australian medicines portfolio
TipRanks · 10/19 07:20
More
About LVCLF
Algorae Pharmaceuticals Limited is an Australia-based artificial-intelligence (AI) enabled pharmaceutical development company. The Company’s proprietary AI platform, Algorae Operating System (AlgoraeOS), is an AI platform that leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. Its other drug candidates include AI-116, AI-168, NTCELL. AI-116 is a combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualized to be a potential treatment for dementia, including Alzheimer’s disease. AI-168 is a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient, which is conceptualized to be a potential treatment for cardiovascular disease, including hypertension. NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells.

Webull offers Algorae Pharmaceuticals Ltd stock information, including OTCPK: LVCLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LVCLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LVCLF stock methods without spending real money on the virtual paper trading platform.